Aphria announced a worldwide license agreement with Manna Molecular Science for the development of patches containing cannabis oils.
Aphria (NYSE:APHA,TSX:APHA) announced a worldwide license agreement with Manna Molecular Science for the development of patches containing cannabis oils.
As quoted in the press release:
“As we continue to expand its use from product to ingredient, we are excited to offer innovative new ways for consumers to interact with cannabis,” said Jakob Ripshtein, President of Aphria. “As a company at the forefront of cannabis innovation, Manna Molecular Science will be an important strategic partner for Aphria. Like us, they are committed to making safe, high-quality cannabis products available to a wide array of global consumers.”
Under the agreement, Manna grants Aphria exclusive preferred vendor status for a period of five years, and an exclusive license to produce, market, distribute, promote and sell Manna patches containing cannabis oil as an active ingredient.
The Conversation (0)
Outlook Reports world
Featured Cannabis Investing News Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES